BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Cantor Fitzgerald
Argus Health
Boehringer Ingelheim

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012151

« Back to Dashboard

NDA 012151 describes ALDACTONE, which is a drug marketed by Gd Searle Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the ALDACTONE profile page.

The generic ingredient in ALDACTONE is spironolactone. There are fifteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the spironolactone profile page.

Summary for 012151

Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 012151

Mechanism of ActionAldosterone Antagonists

Medical Subject Heading (MeSH) Categories for 012151

Suppliers and Packaging for NDA: 012151

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALDACTONE spironolactone TABLET;ORAL 012151 NDA G.D. Searle LLC Division of Pfizer Inc 0025-1001 0025-1001-31 100 TABLET, FILM COATED in 1 BOTTLE (0025-1001-31)
ALDACTONE spironolactone TABLET;ORAL 012151 NDA G.D. Searle LLC Division of Pfizer Inc 0025-1031 0025-1031-31 100 TABLET, FILM COATED in 1 BOTTLE (0025-1031-31)

Summary for product number 008

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 30, 1982TE:ABRLD:Yes

Summary for product number 009

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Dec 30, 1983TE:ABRLD:Yes

Summary for product number 010

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 30, 1983TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: